Please login to the form below

Not currently logged in
Email:
Password:

blood cancer

This page shows the latest blood cancer news and features for those working in and with pharma, biotech and healthcare.

Gilead drug reduces HIV viral reservoir, says researcher

Gilead drug reduces HIV viral reservoir, says researcher

Progress of sorts in eradicating these viral reservoirs was reported this week when a second patient was deemed cured of HIV after receiving a stem cell transplant for a blood cancer, ... Nevertheless, it has encouraged research into therapies that might

Latest news

More from news
Approximately 9 fully matching, plus 238 partially matching documents found.

Latest Intelligence

  • 20 for 2020 – Five pharma companies to watch 20 for 2020 – Five pharma companies to watch

    The company’s biggest play last year was licensing Daiichi Sankyo’s cancer candidate trastuzumab deruxtecan for an eyewatering. ... BMS will become the fourth largest pharma firm by sales – behind Pfizer, Novartis and Roche – and the addition of

  • Cell and gene therapy Cell and gene therapy

    patient.”. Althoff cites Novartis’ Kymriah (tisagenlecleucel), a blood cancer cell therapy approved in Europe and the US last year, as an example of the differing manufacturing costs.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    These include Pfizer’s Daurismo, the first smoothened (SMO) receptor inhibitor to be approved for blood cancer. ... In patients with non-metastatic CRPC, there is a high unmet need to delay development of metastases and the progression to advanced

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Innovative health revenue increased 4% to $8.47bn, lifted by sales of blood thinner Eliquis and breast cancer drug Ibrance outside the US, among others. ... Breast cancer drug Ibrance will be one of the biggest growth drivers for the company, as it looks

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    13 new targeted medicines that block the growth and spread of cancer by interfering with specific molecular targets. ... The CAR-Ts have transformed the treatment of childhood ALL – an otherwise incurable blood cancer – and have been shown to work in

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Life with multiple myeloma - why I'm a lucky man living the dream

    Multiple myeloma patient Bob Munro explains what it's like to live with the rare blood cancer and how his diagnosis led him on the journey of a lifetime – cycling from ... Multiple myeloma patient Bob Munro (pictured below) explains what it's like to

  • Increasing the speed of knowledge sharing in blood cancer to improve patient care

    Spring has sprung and the blood cancer congress calendar is jam-packed with news, science, education and knowledge sharing opportunities. ... This is an exciting and rewarding time to be working in blood cancer, with rapid clinical advances developing in

  • THE OTHER SIDE OF...BLOOD CANCER

    Meet Sophie. What she suffers from you have probably never heard of: a blood cancer, or neoplasm, called  myelofibrosis. ... The environment  is certainly one challenge – busy hospital, many blood cancer patients, so her doctor’s time is limited.

  • Therapy Watch expands oncology and IBD portfolios

    US. CML is a rare cancer affecting the white blood cells and accounts for only 20% of all leukaemias affecting adults. ... Therapy Watch CML is part of a wider oncology portfolio which already covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's

  • New partnership with ELF in 2017

    The White Cell’ is an art installation that allows those affected by blood cancer to release their hidden thoughts and also show how the new ELF Mind and Body Service is

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics